iRhythm Holdings (IRTC) EBIT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -808.01% |
| Dec 31, 2025 | 127.12% |
| Sep 30, 2025 | 54.94% |
| Jun 30, 2025 | 42.54% |
| Mar 31, 2025 | -697.35% |
| Dec 31, 2024 | 91.88% |
| Sep 30, 2024 | -118.89% |
| Jun 30, 2024 | 39.74% |
| Mar 31, 2024 | 2.66% |
| Dec 31, 2023 | -41.95% |
| Sep 30, 2023 | -46.26% |
| Jun 30, 2023 | 52.23% |
| Mar 31, 2023 | -90.86% |
| Dec 31, 2022 | 1.84% |
| Sep 30, 2022 | 10.08% |
| Jun 30, 2022 | 51.70% |
| Mar 31, 2022 | -50.78% |
| Dec 31, 2021 | -38.30% |
| Sep 30, 2021 | -37.02% |
| Jun 30, 2021 | 38.14% |
| Mar 31, 2021 | -186.71% |
| Dec 31, 2020 | -101.41% |
| Sep 30, 2020 | 76.41% |
| Jun 30, 2020 | -119.80% |
| Mar 31, 2020 | 48.25% |
| Dec 31, 2019 | 2.92% |
| Sep 30, 2019 | -72.83% |
| Jun 30, 2019 | -28.78% |
| Mar 31, 2019 | 37.33% |
| Dec 31, 2018 | -41.97% |
| Sep 30, 2018 | 27.85% |
| Jun 30, 2018 | -20.60% |
| Mar 31, 2018 | 3.14% |
| Dec 31, 2017 | -82.88% |
| Sep 30, 2017 | -1.05% |
| Jun 30, 2017 | -24.78% |
| Mar 31, 2017 | -9.13% |
| Dec 31, 2016 | -63.09% |
| Sep 30, 2016 | 27.89% |
| Jun 30, 2016 | 24.10% |
| Mar 31, 2016 | 29.34% |
| Dec 31, 2015 | -25.35% |